Leading doctors sue RFK Jr. over COVID-19 vaccines. Here's why.
On May 27, Kennedy said the shot would no longer be included in the Centers for Disease Control and Prevention's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process.
The health secretary also fired all 17 original members of a federal vaccine panel June 9 and quickly appointed eight new members, including some vaccine skeptics. The panel met for the first time on June 25 but did not make COVID-19 vaccine recommendations for the fall.
The plaintiffs, which include the American Academy of Pediatrics and the Society for Maternal-Fetal Medicine, claim Kennedy's recent decisions were designed to mislead, confuse and desensitize the public to anti-vaccine and anti-science rhetoric. In the July 7 lawsuit filed in Massachusetts, they ask the judge to halt changes made to the COVID-19 vaccine policy.
Vaccine panel on thimerosal: What is that and why is there controversy?
'This wasn't just sidelining science,' said AAP President Dr. Susan Kressly. 'It's an attack on the very foundation of how we protect families and children's health. And the consequences could be dangerous.'
The American College of Physicians, American Public Health Association, Infectious Diseases Society of America, Massachusetts Public Health Alliance and an anonymous pregnant physician were also listed as plaintiffs. The organizations urge parents and patients to follow medical advice published on their websites.
'We will not stand by while a single federal official unilaterally and effectively strips Americans of their choice to vaccinate with actions that thoroughly disregard overwhelming scientific evidence and decades of established federal processes,' said IDSA President Dr. Tina Tan. 'As a community of clinicians, public health officials and scientists, our focus remains the protection of patients and public health.'
USA TODAY reached out to HHS for comment.
Adrianna Rodriguez can be reached at adrodriguez@usatoday.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Epoch Times
27 minutes ago
- Epoch Times
RFK Jr. Accepts Recommendations From Ousted Vaccine Advisers
Health Secretary Robert F. Kennedy Jr. has agreed with advice from an advisory panel that he recently ousted. Kennedy accepted a recommendation from the Advisory Committee on Immunization Practices (ACIP) that vaccines against respiratory syncytial virus (RSV) be recommended for adults aged 50 to 59 who have a factor that places them at increased risk of severe illness, according to an update on the Centers for Disease Control and Prevention's website.
Miami Herald
2 hours ago
- Miami Herald
Formerly bankrupt weight-loss company makes a comeback
When it comes to things that most concern Americans about their health, weight loss is often at the top of the list. While America doesn't have the top obesity rate in the world, it does rank high on the list. More than 45% of Americans are obese. But the issue is bigger than just in the country - the worldwide rate of adult obesity has more than doubled since 1990, per the World Health Organization. Don't miss the move: Subscribe to TheStreet's free daily newsletter Attempts to solve this problem have spawned a thriving diet industry, always promoting the next pill, diet plan, or weight-loss gimmick to those desperate to attain better health. These approaches have all propelled the U.S. weight-loss market to grow over the decades, but the birth of GLP-1 drugs such as Ozempic sent it to new heights in 2023, with a market value of $90 billion. Related: One of Oprah's favorite things prepares for Chapter 11 bankruptcy It's a profitable market, but also an overcrowded one, and trying to get people's attention and stay on the cutting edge of what appeals to consumers presents a daunting challenge that businesses must continually navigate. Now, after one of the best-known names in the industry seemed to be on the edge of extinction, it's making a turnaround that few could have predicted - and with a new focus on a long-ignored women's issue. After declaring Chapter 11 bankruptcy in May of 2025, once-giant WeightWatchers (rebranded to WW beginning in 2018) admitted its $1.5 billion in debt was too big of a burden to continue to bear. The bankruptcy process would eliminate that debt, the company said, and it expected to reemerge as a publicly traded company. "The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members, and lead with authority in a rapidly evolving weight management landscape," said CEO Tara Comonte in a release at the time. Related: WeightWatchers takes drastic step to exit bankruptcy WeightWatchers made its debut in the '60s, at a time when diet and portion control were a focus, and enjoyed many decades of success. The company also got a significant boost when Oprah partnered with it in 2015. WeightWatchers has now emerged from that bankruptcy with a new focus: helping middle-aged women struggling with all stages of menopause, from peri to post. The new program will offer access to prescription treatments such as hormone replacement therapy and also help women connect with resources for behavioral and nutritional support, WeightWatchers said. The company also named Dr. Kim Boyd as its new chief medical officer. Boyd has worked in leadership at One Medical, Calibrate, Caire, Galileo, and Nurx in the past and has co-founded or scaled multiple consumer health companies. Menopause care has been a hot topic as of late, with high-profile actresses such as Naomi Watts founding new companies to support women going through it. After Watts experienced early menopause at 36, she founded Stripes Beauty, a brand that sells products aimed at women in all stages of the life change. WW's new angle could provide the first large-scale platform for menopausal women, which could take advantage of a once-taboo topic that's slowly gained more attention in recent years. Related: Red-hot weight-loss drug stock tanks after surprise pharma giant decision The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
The Hill
2 hours ago
- The Hill
In reversal, Trump administration will defend Biden's asbestos ban
The Trump administration says it will uphold a Biden-era ban on the ongoing use of asbestos after previously saying it would reconsider the rule. In a court filing last month, the Environmental Protection Agency (EPA) had said that it planned to pursue a rulemaking process that could make changes to the ban. However, in a Monday court filing, it withdrew that previous motion, saying it 'no longer intends to conduct … rulemaking to evaluate potential changes at this time.' In an additional court filing, Lynn Dekleva, an official in the EPA's Office of Chemical Safety and Pollution Prevention, said that the administration could try to instead use a guidance to alter how the rule is implemented. 'EPA plans to explore whether guidance could provide further clarity to stakeholders as they implement the Rule, particularly with respect to any workplace protection measures,' Dekleva's declaration states. But the declaration means that the Trump administration will defend the asbestos ban in court after challenges from the chemical industry and others. The Biden-era rule requires companies to phase out their uses of a type of asbestos known as chrysotile asbestos, which is the only known type used in the U.S. The rule gave companies making automotive breaks six months to stop making products with asbestos, while other industries got more time. Most sheet gaskets, a type of seal, that contain asbestos will be banned after two years, while the chlor-alkali sector, which makes chemicals like chlorine for treating water, will have up to 12 years to make the change. Exposure to asbestos causes lung cancer and mesothelioma, a rare cancer that occurs in the lining of the lung, chest and the abdomen and heart. Asbestos-related diseases are estimated to kill thousands of Americans each year. Michelle Roos, executive director of the Environmental Protection Network, a group of former EPA employees, called the administration's latest court filing a 'step in the right direction' in a written statement, saying it came in the wake of 'fierce public pressure and legal accountability. 'This is just the beginning of the public backlash against the Trump administration's plans to roll back 31 standards that protect the air we breathe and the water we drink,' Roos said. A number of Trump administration officials have ties to the chemical industry, including the agency's deputy administrator, who represented a group of car companies that argued against the asbestos ban in a legal filing last year.
